PFDSelect Medical Receivables 1021, LLC has made significant updates to its offering, as detailed in a recent SEC filing. The company has successfully raised over $1.2 million toward its goal of $10 million. This amendment highlights the growing interest in medical receivables financing, an area that continues to attract investor attention.

The filing reveals that PFDSelect is focusing on equity-type securities, which could broaden its appeal to a variety of investors. This move comes as the healthcare finance sector continues to evolve, with companies like PFDSelect positioning themselves to capitalize on emerging opportunities.

Background

PFDSelect Medical Receivables 1021, LLC is a limited liability company incorporated in Nevada. The company is part of the Other Banking and Financial Services industry group. It has no publicly traded tickers or exchanges listed. The company’s recent filings include an amendment to its offering on October 29, 2026, and an initial filing on July 30, 2026.

What the Filing Says

The recent filing indicates that the total offering amount is set at $10 million, with $1,270,432 already sold. The remaining amount to be raised is $8,729,568. The filing states, "The date of first sale was August 6, 2026," and emphasizes that the offering duration is more than one year.

Impact

This update may affect various stakeholders, including investors interested in medical receivables financing. The company has reported that it has nine investors already involved in this offering, all of whom are accredited. The focus on equity-type securities may attract further interest from potential investors looking for opportunities in healthcare finance.

What's Next

The filing does not say what happens next.